A halogenated polysaccharide is provided having a halogen content of from about 1.0 wt. % to about 85 wt. % based on the total weight of the halogenated polysaccharide and having an average chain length of at least 6 monosaccharides. Methods of halogenating a polysaccharide to form a halogenated polysaccharide are provided that can be performed in the presence or absence of a proton solvent. Compositions such as articles of manufacture containing a halogenated polysaccharide and methods of producing such articles are also provided. The article of manufacture can also include one or more additional polymers, for example, polyvinylchloride (PVC). The article of manufacture can be, for example, a flooring tile, flooring plank, or carpet. Halogenated polysaccharides and products containing the same are bio-based, environmentally sustainable replacements or complements to existing polymers and polymer products.

A halogenated polysaccharide is provided having a halogen content of from about 1.0 wt. % to about 85 wt. % based on the total weight of the halogenated polysaccharide and having an average chain length of at least 6 monosaccharides. Methods of halogenating a polysaccharide to form a halogenated polysaccharide are provided that can be performed in the presence or absence of a proton solvent. Compositions such as articles of manufacture containing a halogenated polysaccharide and methods of producing such articles are also provided. The article of manufacture can also include one or more additional polymers, for example, polyvinylchloride (PVC). The article of manufacture can be, for example, a flooring tile, flooring plank, or carpet. Halogenated polysaccharides and products containing the same are bio-based, environmentally sustainable replacements or complements to existing polymers and polymer products.

Particles having excellent touch properties are achieved with a water-soluble material having excellent biodegradability. Particles according to the present invention contain a starch having an amylopectin content of 90% by weight or more. The average particle diameter d.sub.1 of the panicles is 0.5 to 20 μm, and the maximum particle diameter d.sub.2 is less than 30 μm while being within 3.0 times the average particle diameter.

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.

Compositions are disclosed for dewatering mixtures of petroleum and water. The compositions comprise one or more of the following: an unreacted polysaccharide component; and one or both of a polysaccharide component reacted with a hydrophilic component and a polysaccharide component reacted with a hydrophobic component. The compositions may also include viscosifying agents or stabilizers to stabilize the compositions against separation, for example, prior to use. In particularly preferred embodiments the invention is drawn to compositions for breaking an emulsion; such compositions comprising a carbohydrate component containing a cationic starch joined to a hydrophobic moiety, providing the carbohydrate component oil solubility. The composition may optionally comprise one or more additional demulsifier selected from, without limitation, salts (such as a polyaluminum chloride, an aluminum chlorohydrate, an alum, etc.), metal salts (such as iron and zinc salts), dithiocarbamate, tannin, and organic demulsifiers such as poly-DADMAC and similar compounds.

Compositions are disclosed for dewatering mixtures of petroleum and water. The compositions comprise one or more of the following: an unreacted polysaccharide component; and one or both of a polysaccharide component reacted with a hydrophilic component and a polysaccharide component reacted with a hydrophobic component. The compositions may also include viscosifying agents or stabilizers to stabilize the compositions against separation, for example, prior to use. In particularly preferred embodiments the invention is drawn to compositions for breaking an emulsion; such compositions comprising a carbohydrate component containing a cationic starch joined to a hydrophobic moiety, providing the carbohydrate component oil solubility. The composition may optionally comprise one or more additional demulsifier selected from, without limitation, salts (such as a polyaluminum chloride, an aluminum chlorohydrate, an alum, etc.), metal salts (such as iron and zinc salts), dithiocarbamate, tannin, and organic demulsifiers such as poly-DADMAC and similar compounds.

Compositions are disclosed for dewatering mixtures of petroleum and water. The compositions comprise one or more of the following: an unreacted polysaccharide component; and one or both of a polysaccharide component reacted with a hydrophilic component and a polysaccharide component reacted with a hydrophobic component. The compositions may also include viscosifying agents or stabilizers to stabilize the compositions against separation, for example, prior to use. In particularly preferred embodiments the invention is drawn to compositions for breaking an emulsion; such compositions comprising a carbohydrate component containing a cationic starch joined to a hydrophobic moiety, providing the carbohydrate component oil solubility. The composition may optionally comprise one or more additional demulsifier selected from, without limitation, salts (such as a polyaluminum chloride, an aluminum chlorohydrate, an alum, etc.), metal salts (such as iron and zinc salts), dithiocarbamate, tannin, and organic demulsifiers such as poly-DADMAC and similar compounds.

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.